<DOC>
	<DOCNO>NCT00350636</DOCNO>
	<brief_summary>A new drug overactive bladder compare placebo determine safe effective . The study last approximately 12 week .</brief_summary>
	<brief_title>A Comparison New Drug Treat Overactive Bladder v . Placebo</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Females male , 18 year older overactive bladder symptom Treatable condition may cause urinary incontinence Medical condition would unsafe use anticholinergic agent . The use concomitant drug would confound efficacy evaluation . The use concomitant drug would unsafe anticholinergic agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>OAB , anticholineric , oxybutynin , urge urinary incontinence</keyword>
</DOC>